Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharma News Only (pfe,mrk,wla, sgp, ahp, bmy, lly)

PFE 24.31

0.0%

Oct 30 3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DavesM who wrote (1694)	8/1/2001 9:47:26 PM
From: darbyred	of 1722

It would certainly help; however, it is more than the 20 mg prozac that is being "lost." Apparently Dr. Reddy (RDY) has short term exclusive rights to sell the 40mg generic prozac and PRI has rights to sell generic prozac in another dosage. If the generics (including Barr (BRL)) are successful, Lilly will probably lose substantially more than half its prozac revenue within six months. IMHO.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next